Publications

  1. Dalland JC, Dao LN, Dasari S, Theis JD, Chiu A, Rech KL, Howard MT, Grogan M, Hagen C, Bois MC, McPhail ED. Dual AApoAIV amyloidosis and ATTR amyloidosis arising in the same patient: a report of three cases. Amyloid. 2024 Jun; 31 (2):153-155 Epub 2023 Dec 15
    View PubMed
  2. Pereyra Pietri M, Farina JM, Mahmoud AK, Scalia IG, Galasso F, Killian ME, Suppah M, Kenyon CR, Koepke LM, Padang R, Chao CJ, Sweeney JP, Fortuin FD, Eleid MF, Sell-Dottin KA, Steidley DE, Scott LR, Fonseca R, Lopez-Jimenez F, Attia ZI, Dispenzieri A, Grogan M, Rosenthal JL, Arsanjani R, Ayoub C. The prognostic value of artificial intelligence to predict cardiac amyloidosis in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement. Eur Heart J Digit Health. 2024 May; 5 (3):295-302 Epub 2024 Mar 13
    View PubMed
  3. Chao CJ, Jeong J, Arsanjani R, Kim K, Tsai YL, Yu WC, Farina JM, Mahmoud AK, Ayoub C, Grogan M, Kane GC, Banerjee I, Oh JK. Echocardiography-Based Deep Learning Model to Differentiate Constrictive Pericarditis and Restrictive Cardiomyopathy. JACC Cardiovasc Imaging. 2024 Apr; 17 (4):349-360 Epub 2023 Nov 08
    View PubMed
  4. Abbasi MA, El-Am E, Deshmukh A, Dispenzieri A, Grogan M, Ezzeddine OA, Lin G. Long-Term, Implantable Event Monitoring of Patients With Wild-Type Transthyretin Cardiac Amyloidosis: A Pilot Study. JACC CardioOncol. 2024 Apr; 6 (2):313-314 Epub 2024 Feb 27
    View PubMed
  5. Gonzalez-Lopez E, McPhail ED, Salas-Anton C, Dominguez F, Gertz MA, Dispenzieri A, Dasari S, Milani P, Verga L, Grogan M, Palladini G, Garcia-Pavia P. Histological Typing in Patients With Cardiac Amyloidosis: JACC Review Topic of the Week. J Am Coll Cardiol. 2024 Mar 19; 83 (11):1085-1099
    View PubMed
  6. Gonzalez-Moreno J, Dispenzieri A, Grogan M, Coelho T, Tournev I, Waddington-Cruz M, Wixner J, Diemberger I, Garcia-Pavia P, Chapman D, Gupta P, Glass O, Amass L, THAOS investigators. Clinical and Genotype Characteristics and Symptom Migration in Patients With Mixed Phenotype Transthyretin Amyloidosis from the Transthyretin Amyloidosis Outcomes Survey. Cardiol Ther. 2024 Mar; 13 (1):117-135 Epub 2023 Dec 20
    View PubMed
  7. Wardhere A, Bampatsias D, Fine N, Garcia-Pavia P, Grogan M, Kristen AV, Damy T, Sekijima Y, Maurer MS. Heterogeneous worldwide access and pricing of Tafamidis. Amyloid. 2024 Mar; 31 (1):73-75 Epub 2023 Oct 03
    View PubMed
  8. Grogan M, Davis MK, Crespo-Leiro MG, Sultan MB, Gundapaneni B, Stedile Angeli F, Hanna M. Effect of long-term tafamidis treatment on health-related quality of life in patients with transthyretin amyloid cardiomyopathy. Eur J Heart Fail. 2024 Mar; 26 (3):612-615 Epub 2024 Mar 04
    View PubMed
  9. Garcia-Pavia P, Grogan M, Kale P, Berk JL, Maurer MS, Conceicao I, Di Carli M, Solomon SD, Chen C, Yureneva E, Vest J, Gillmore JD. Impact of vutrisiran on exploratory cardiac parameters in hereditary transthyretin-mediated amyloidosis with polyneuropathy. Eur J Heart Fail. 2024 Feb; 26 (2):397-410 Epub 2024 Feb 06
    View PubMed
  10. Gillmore JD, Judge DP, Cappelli F, Fontana M, Garcia-Pavia P, Gibbs S, Grogan M, Hanna M, Hoffman J, Masri A, Maurer MS, Nativi-Nicolau J, Obici L, Poulsen SH, Rockhold F, Shah KB, Soman P, Garg J, Chiswell K, Xu H, Cao X, Lystig T, Sinha U, Fox JC, ATTRibute-CM Investigators. Efficacy and Safety of Acoramidis in Transthyretin Amyloid Cardiomyopathy. N Engl J Med. 2024 Jan 11; 390 (2):132-142
    View PubMed
  11. Ismayl M, Abbasi M, Al-Abcha A, El-Am E, Alkhouli M, Guerrero M, Dispenzieri A, Nkomo VT, Abou Ezzeddine OF, Grogan M, Anavekar NS. Outcomes of transcatheter aortic valve replacement in patients with and without amyloidosis: A nationwide analysis from the United States. Cardiovasc Revasc Med. 2024 Jan; 58:34-42 Epub 2023 July 17
    View PubMed
  12. Slart RHJA, Chen W, Tubben A, Tingen HSA, Davies DR, Grogan M, Wechalekar AD, Kittleson MM, Thomson LEJ, Slomka PJ, Wechalekar K, Chareonthaitawee P. Emerging Role of Scintigraphy Using Bone-Seeking Tracers for Diagnosis of Cardiac Amyloidosis: AJR Expert Panel Narrative Review. AJR Am J Roentgenol. 2024 Jan; 222 (1):e2329347 Epub 2023 June 14
    View PubMed
  13. Gentile L, Diemberger I, Plante-Bordeneuve V, Mazzeo A, Dori A, Luigetti M, Di Paolantonio A, Dispenzieri A, Grogan M, Waddington Cruz M, Adams D, Inamo J, Kristen AV, Lino Cirami C, Chapman D, Gupta P, Glass O, Amass L. Phenotypic characteristics of F64L, I68L, I107V, and S77Y ATTRv genotypes from the Transthyretin Amyloidosis Outcomes Survey (THAOS). PLoS One. 2024; 19 (1):e0292435 Epub 2024 Jan 19
    View PubMed
  14. Gilani SI, Dasari S, Tekin B, Hernandez LH, Cheville JC, Jimenez RE, Rech KL, Dao LN, Howard MT, Dalland JC, Chiu A, Theis JD, Vrana JA, Grogan M, Thompson RH, Leibovich BC, Karnes RJ, Boorjian SA, Dispenzieri A, McPhail ED, Gupta S. Identification of amyloidosis of the urinary tract and prostate: Opportunities for early diagnosis & intervention in systemic disease. Hum Pathol. 2023 Dec; 142:62-67. Epub 2023 Nov 17.
    View PubMed
  15. Coelho T, Dispenzieri A, Grogan M, Conceicao I, Waddington-Cruz M, Kristen AV, Wixner J, Diemberger I, Gonzalez-Moreno J, Maurer MS, Plante-Bordeneuve V, Garcia-Pavia P, Tournev I, Gonzalez-Costello J, Cariou E, Gonzalez-Duarte A, Glass O, Chapman D, Amass L, THAOS investigators. Patients with transthyretin amyloidosis enrolled in THAOS between 2018 and 2021 continue to experience substantial diagnostic delay. Amyloid. 2023 Dec; 30 (4):445-448 Epub 2023 July 17
    View PubMed
  16. Gentile L, Coelho T, Dispenzieri A, Conceicao I, Waddington-Cruz M, Kristen A, Wixner J, Diemberger I, Gonzalez-Moreno J, Cariou E, Maurer MS, Plante-Bordeneuve V, Garcia-Pavia P, Tournev I, Gonzalez-Costello J, Duarte AG, Grogan M, Mazzeo A, Chapman D, Gupta P, Glass O, Amass L, THAOS investigators. A 15-year consolidated overview of data in over 6000 patients from the Transthyretin Amyloidosis Outcomes Survey (THAOS). Orphanet J Rare Dis. 2023 Nov 10; 18 (1):350
    View PubMed
  17. Maurer MS, Kale P, Fontana M, Berk JL, Grogan M, Gustafsson F, Hung RR, Gottlieb RL, Damy T, Gonzalez-Duarte A, Sarswat N, Sekijima Y, Tahara N, Taylor MS, Kubanek M, Donal E, Palecek T, Tsujita K, Tang WHW, Yu WC, Obici L, Simoes M, Fernandes F, Poulsen SH, Diemberger I, Perfetto F, Solomon SD, Di Carli M, Badri P, White MT, Chen J, Yureneva E, Sweetser MT, Jay PY, Garg PP, Vest J, Gillmore JD, APOLLO-B Trial Investigators. Patisiran Treatment in Patients with Transthyretin Cardiac Amyloidosis. N Engl J Med. 2023 Oct 26; 389 (17):1553-1565
    View PubMed
  18. Nandy S, Hajra A, Bandyopadhyay D, Malik A, Mankad R, Grogan M, Abou Ezzeddine O, Klarich KW. Trends in the Prevalence of Infiltrative Cardiomyopathy Among Patients With in-Hospital Cardiac Arrest. Curr Probl Cardiol. 2023 Oct; 48 (10):101819 Epub 2023 May 20
    View PubMed
  19. Harmon DM, Mangold K, Suarez AB, Scott CG, Murphree DH, Malik A, Attia ZI, Lopez-Jimenez F, Friedman PA, Dispenzieri A, Grogan M. Postdevelopment Performance and Validation of the Artificial Intelligence-Enhanced Electrocardiogram for Detection of Cardiac Amyloidosis. JACC Adv. 2023 Oct; 2 (8) Epub 2023 Sept 14
    View PubMed
  20. Jeong J, Chao CJ, Arsanjani R, Kim K, Pelkey MN, Chen YC, Ramzan RN, Elbahnasawy M, Sleem M, Ayoub C, Farina JMM, Grogan M, Kane GC, Patel BN, Oh JK, Banerjee I. Challenges and solutions of echocardiography generalization for deep learning: a study in patients with constrictive pericarditis. J Med Imaging (Bellingham). 2023 Sep; 10 (5):054502 Epub 2023 Oct 12
    View PubMed
  21. Young KA, Lyle M, Rosenbaum AN, Chang IC, Lin G, Bois MC, Ezzeddine OFA, Jouni H, Chareonthaitawee P, Kapa S, Grogan M, Cooper LT, Blauwet L, Bois JP. (18)F-FDG/(13)N-ammonia cardiac PET findings in ATTR cardiac amyloidosis. J Nucl Cardiol. 2023 Apr; 30 (2):726-735 Epub 2022 Jan 27
    View PubMed
  22. Li J, Chao CJ, Jeong JJ, Farina JM, Seri AR, Barry T, Newman H, Campany M, Abdou M, O'Shea M, Smith S, Abraham B, Hosseini SM, Wang Y, Lester S, Alsidawi S, Wilansky S, Steidley E, Rosenthal J, Ayoub C, Appleton CP, Shen WK, Grogan M, Kane GC, Oh JK, Patel BN, Arsanjani R, Banerjee I. Developing an Echocardiography-Based, Automatic Deep Learning Framework for the Differentiation of Increased Left Ventricular Wall Thickness Etiologies. J Imaging. 2023 Feb 18; 9(2).
    View PubMed
  23. Grogan M, Lopez-Jimenez F, Cohen-Shelly M, Dispenzieri A, Attia ZI, Abou Ezzedine OF, Lin GC, Kapa S, Borgeson DD, Friedman PA, Murphree DH Jr. Corrigendum to 'Artificial intelligence-enhanced electrocardiogram for the early detection of cardiac amyloidosis' [Mayo Clinic Proceedings 96 (2021) 2768-2778]. Mayo Clinic Proceedings. 2023 Jan; 98 (1):211
  24. Gonzalez-Lopez E, Escobar-Lopez L, Obici L, Saturi G, Bezard M, Saith SE, AbouEzzeddine OF, Mussinelli R, Gagliardi C, Kharoubi M, Griffin JM, Dispenzieri A, Vilches S, Perlini S, Longhi S, Oghina S, Rivas A, Grogan M, Maurer MS, Damy T, Palladini G, Rapezzi C, Garcia-Pavia P. Prognosis of Transthyretin Cardiac Amyloidosis Without Heart Failure Symptoms. JACC CardioOncol. 2022 Nov; 4 (4):442-454 Epub 2022 Nov 15
    View PubMed
  25. Minnema MC, Dispenzieri A, Merlini G, Comenzo RL, Kastritis E, Wechalekar AD, Grogan M, Witteles R, Ruberg FL, Maurer MS, Tran N, Qin X, Vasey SY, Weiss BM, Vermeulen J, Jaccard A. Outcomes by Cardiac Stage in Patients With Newly Diagnosed AL Amyloidosis: Phase 3 ANDROMEDA Trial. JACC CardioOncol. 2022 Nov; 4 (4):474-487 Epub 2022 Nov 15
    View PubMed
  26. Davies DR, Redfield MM, Scott CG, Minamisawa M, Grogan M, Dispenzieri A, Chareonthaitawee P, Shah AM, Shah SJ, Wehbe RM, Solomon SD, Reddy YNV, Borlaug BA, AbouEzzeddine OF. A Simple Score to Identify Increased Risk of Transthyretin Amyloid Cardiomyopathy in Heart Failure With Preserved Ejection Fraction. JAMA Cardiol. 2022 Oct 1; 7 (10):1036-1044
    View PubMed
  27. Alsomali D, Mohty D, Grogan M, Dispenzieri A, Aljurf M, Kumar S, Gertz MA, Hanbali A, Hashmi SK. Treatment of amyloid light chain cardiac amyloidosis: systematic review and future directions. Clin Adv Hematol Oncol. 2022 Oct; 20 (10):609-618
    View PubMed
  28. Chiu A, Dasari S, Kurtin PJ, Theis JD, Vrana JA, Dispenzieri A, Rech KL, Dao LN, Howard MT, Grogan M, McPhail ED. Bone marrow amyloid: a comprehensive analysis of 1,469 samples, including amyloid type, clinical features, and morphologic distribution. Amyloid. 2022 Sep; 29 (3):156-164 Epub 2022 Feb 09
    View PubMed
  29. Campbell CM, LoRusso S, Dispenzieri A, Kristen AV, Maurer MS, Rapezzi C, Lairez O, Drachman B, Garcia-Pavia P, Grogan M, Chapman D, Amass L, THAOS investigators. Sex Differences in Wild-Type Transthyretin Amyloidosis: An Analysis from the Transthyretin Amyloidosis Outcomes Survey (THAOS). Cardiol Ther. 2022 Sep; 11 (3):393-405 Epub 2022 May 18
    View PubMed
  30. Dispenzieri A, Coelho T, Conceicao I, Waddington-Cruz M, Wixner J, Kristen AV, Rapezzi C, Plante-Bordeneuve V, Gonzalez-Moreno J, Maurer MS, Grogan M, Chapman D, Amass L, THAOS investigators. Clinical and genetic profile of patients enrolled in the Transthyretin Amyloidosis Outcomes Survey (THAOS): 14-year update. Orphanet J Rare Dis. 2022 Jun 18; 17 (1):236 Epub 2022 June 18
    View PubMed
  31. Nativi-Nicolau J, Judge DP, Hoffman JE, Gundapaneni B, Keohane D, Sultan MB, Grogan M. How did transthyretin amyloid cardiomyopathy progress in patients who took placebo in the study ATTR-ACT? A plain language summary. Future Cardiol. 2022 Mar 17 [Epub ahead of print]
    View PubMed
  32. Hanna M, Damy T, Grogan M, Stewart M, Gundapaneni B, Sultan MB, Maurer MS. Tafamidis and quality of life in people with transthyretin amyloid cardiomyopathy in the study ATTR-ACT: A plain language summary. Future Cardiol. 2022 Mar; 18 (3):165-172 Epub 2021 Nov 15
    View PubMed
  33. Vaxman I, Kumar SK, Buadi F, Lacy MQ, Dingli D, Hwa Y, Fonder A, Hobbs M, Hayman S, Kourelis T, Warsame R, Muchtar E, Leung N, Kapoor P, Grogan M, Go R, Lin Y, Gonsalves W, Siddiqui M, Kyle RA, Rajkumar SV, Gertz MA, Dispenzieri A. Outcomes among newly diagnosed AL amyloidosis patients with a very high NT-proBNP: implications for trial design. Leukemia 2021 Dec; 35 (12):3604-3607 Epub 2021 May 21
    View PubMed
  34. AbouEzzeddine OF, Davies DR, Scott CG, Fayyaz AU, Askew JW, McKie PM, Noseworthy PA, Johnson GB, Dunlay SM, Borlaug BA, Chareonthaitawee P, Roger VL, Dispenzieri A, Grogan M, Redfield MM. Prevalence of Transthyretin Amyloid Cardiomyopathy in Heart Failure With Preserved Ejection Fraction. JAMA Cardiol. 2021 Nov 1; 6 (11):1267-1274
    View PubMed
  35. Grogan M, Lopez-Jimenez F, Cohen-Shelly M, Dispenzieri A, Attia ZI, Abou Ezzedine OF, Lin G, Kapa S, Borgeson DD, Friedman PA, Murphree DH Jr. Artificial Intelligence-Enhanced Electrocardiogram for the Early Detection of Cardiac Amyloidosis. Mayo Clin Proc. 2021 Nov; 96 (11):2768-2778 Epub 2021 July 02
    View PubMed
  36. Griffin JM, Rosenthal JL, Grodin JL, Maurer MS, Grogan M, Cheng RK. ATTR Amyloidosis: Current and Emerging Management Strategies: JACC: CardioOncology State-of-the-Art Review. JACC CardioOncol. 2021 Oct; 3 (4):488-505 Epub 2021 Oct 19
    View PubMed
  37. Nativi-Nicolau J, Judge DP, Hoffman JE, Gundapaneni B, Keohane D, Sultan MB, Grogan M. Natural history and progression of transthyretin amyloid cardiomyopathy: insights from ATTR-ACT. ESC Heart Fail. 2021 Oct; 8(5):3875-3884. Epub 2021 Aug 25.
    View PubMed
  38. Nativi-Nicolau J, Siu A, Dispenzieri A, Maurer MS, Rapezzi C, Kristen AV, Garcia-Pavia P, LoRusso S, Waddington-Cruz M, Lairez O, Witteles R, Chapman D, Amass L, Grogan M, THAOS Investigators. Temporal Trends of Wild-Type Transthyretin Amyloid Cardiomyopathy in the Transthyretin Amyloidosis Outcomes Survey. JACC CardioOncol. 2021 Oct; 3 (4):537-546 Epub 2021 Oct 19
    View PubMed
  39. El-Am EA, Ahmad A, Dispenzieri A, Grogan M, Nkomo VT. Cardiac Amyloidosis in Patients With Persistent Left Atrial Thrombus. J Am Coll Cardiol 2021 Sep 28; 78 (13):e87
    View PubMed
  40. Muchtar E, Dispenzieri A, Gertz MA, Kumar SK, Buadi FK, Leung N, Lacy MQ, Dingli D, Ailawadhi S, Bergsagel PL, Fonseca R, Hayman SR, Kapoor P, Grogan M, Abou Ezzeddine OF, Rosenthal JL, Mauermann M, Siddiqui M, Gonsalves WI, Kourelis TV, Larsen JT, Reeder CB, Warsame R, Go RS, Murray DL, McPhail ED, Dasari S, Jevremovic D, Kyle RA, Lin Y, Lust JA, Russell SJ, Hwa YL, Fonder AL, Hobbs MA, Rajkumar SV, Roy V, Sher T. Treatment of AL Amyloidosis: Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consensus Statement 2020 Update. Mayo Clin Proc. 2021 Jun; 96(6):1546-1577.
    View PubMed
  41. Hill MM, Dasari S, Mollee P, Merlini G, Costello CE, Hazenberg BPC, Grogan M, Dispenzieri A, Gertz MA, Kourelis T, McPhail ED. The Clinical Impact of Proteomics in Amyloid Typing. Mayo Clin Proc. 2021 May; 96 (5):1122-1127 Epub 2021 Apr 09
    View PubMed
  42. Garcia-Pavia P, Rapezzi C, Adler Y, Arad M, Basso C, Brucato A, Burazor I, Caforio ALP, Damy T, Eriksson U, Fontana M, Gillmore JD, Gonzalez-Lopez E, Grogan M, Heymans S, Imazio M, Kindermann I, Kristen AV, Maurer MS, Merlini G, Pantazis A, Pankuweit S, Rigopoulos AG, Linhart A. Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2021 Apr 21; 42 (16):1554-1568
    View PubMed
  43. Garcia-Pavia P, Rapezzi C, Adler Y, Arad M, Basso C, Brucato A, Burazor I, Caforio ALP, Damy T, Eriksson U, Fontana M, Gillmore JD, Gonzalez-Lopez E, Grogan M, Heymans S, Imazio M, Kindermann I, Kristen AV, Maurer MS, Merlini G, Pantazis A, Pankuweit S, Rigopoulos AG, Linhart A. Diagnosis and treatment of cardiac amyloidosis. A position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur J Heart Fail. 2021 Apr; 23 (4):512-526 Epub 2021 Apr 07
    View PubMed
  44. Muchtar E, Dispenzieri A, Magen H, Grogan M, Mauermann M, McPhail ED, Kurtin PJ, Leung N, Buadi FK, Dingli D, Kumar SK, Gertz MA. Systemic amyloidosis from A (AA) to T (ATTR): a review. J Intern Med. 2021 Mar; 289 (3):268-292 Epub 2020 Sept 14
    View PubMed
  45. Hanna M, Damy T, Grogan M, Stewart M, Gundapaneni B, Patterson TA, Schwartz JH, Sultan MB, Maurer MS. Impact of Tafamidis on Health-Related Quality of Life in Patients With Transthyretin Amyloid Cardiomyopathy (from the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial). Am J Cardiol. 2021 Feb 15; 141:98-105 Epub 2020 Nov 19
    View PubMed
  46. Dasari S, Dispenzieri A, Mansour S, Muppa P, Kurtin PJ, Theis JD, Vrana JA, Grogan M, Kourelis T, Gertz MA, McPhail ED. Non-cardiac biopsy sites with high frequency of transthyretin amyloidosis. ESC Heart Fail. 2021 Feb; 8 (1):750-755 Epub 2020 Dec 05
    View PubMed
  47. El-Am EA, Grogan M, Ahmad A, Patlolla SH, Klarich KW, AbouEzzeddine OF, Melduni RM, Maleszewski JJ, Dispenzieri A, Nkomo VT. Persistence of Left Atrial Appendage Thrombus in Patients With Cardiac Amyloidosis. J Am Coll Cardiol 2021 Jan 26; 77 (3):342-343
    View PubMed
  48. Muchtar E, King RL, McPhail ED, Thorpe MP, Gonsalves W, Ernste F, Grogan M, Dispenzieri A, Gertz MA. Amyloid arthropathy in smoldering myeloma: Do not take it lightly. Leuk Res Rep. 2021; 15:100242 Epub 2021 Apr 24
    View PubMed
  49. Judge DP, Kristen AV, Grogan M, Maurer MS, Falk RH, Hanna M, Gillmore J, Garg P, Vaishnaw AK, Harrop J, Powell C, Karsten V, Zhang X, Sweetser MT, Vest J, Hawkins PN. Correction to: Phase 3 Multicenter Study of Revusiran in Patients with Hereditary Transthyretin-Mediated (hATTR) Amyloidosis with Cardiomyopathy (ENDEAVOUR). Cardiovasc Drugs Ther. 2020 Dec; 34 (6):889
    View PubMed
  50. Nevo A, Muchtar E, Stern KL, Moore JP, Cheney SM, Humphreys MR, Grogan M, Stanton ML. The Clinical Implication of Incidental Prostatic Amyloidosis. Urology. 2020 Nov; 145:253-257 Epub 2020 Sept 19
    View PubMed
  51. Kourelis TV, Dasari SS, Dispenzieri A, Maleszewski JJ, Redfield MM, Fayyaz AU, Grogan M, Ramirez-Alvarado M, Abou Ezzeddine OF, McPhail ED. A Proteomic Atlas of Cardiac Amyloid Plaques. JACC CardioOncol. 2020 Nov; 2 (4):632-643 Epub 2020 Nov 17
    View PubMed
  52. Gertz M, Adams D, Ando Y, Beirao JM, Bokhari S, Coelho T, Comenzo RL, Damy T, Dorbala S, Drachman BM, Fontana M, Gillmore JD, Grogan M, Hawkins PN, Lousada I, Kristen AV, Ruberg FL, Suhr OB, Maurer MS, Nativi-Nicolau J, Quarta CC, Rapezzi C, Witteles R, Merlini G. Avoiding misdiagnosis: expert consensus recommendations for the suspicion and diagnosis of transthyretin amyloidosis for the general practitioner. BMC Fam Pract. 2020 Sep 23; 21 (1):198 Epub 2020 Sept 23
    View PubMed
  53. Hanna M, Ruberg FL, Maurer MS, Dispenzieri A, Dorbala S, Falk RH, Hoffman J, Jaber W, Soman P, Witteles RM, Grogan M. Cardiac Scintigraphy With Technetium-99m-Labeled Bone-Seeking Tracers for Suspected Amyloidosis: JACC Review Topic of the Week. J Am Coll Cardiol. 2020 Jun 9; 75 (22):2851-2862
    View PubMed
  54. Judge DP, Kristen AV, Grogan M, Maurer MS, Falk RH, Hanna M, Gillmore J, Garg P, Vaishnaw AK, Harrop J, Powell C, Karsten V, Zhang X, Sweetser MT, Vest J, Hawkins PN. Phase 3 Multicenter Study of Revusiran in Patients with Hereditary Transthyretin-Mediated (hATTR) Amyloidosis with Cardiomyopathy (ENDEAVOUR). Cardiovasc Drugs Ther. 2020 Jun; 34 (3):357-370
    View PubMed
  55. Fayyaz AU, Bois MC, Dasari S, Padmanabhan D, Vrana JA, Stulak JM, Edwards WD, Kurtin PJ, Asirvatham SJ, Grogan M, Maleszewski JJ. Amyloidosis in surgically resected atrial appendages: a study of 345 consecutive cases with clinical implications. Mod Pathol. 2020 May; 33 (5):764-774 Epub 2019 Nov 13
    View PubMed
  56. Muchtar E, Lin G, Grogan M. The Challenges in Chemotherapy and Stem Cell Transplantation for Light-Chain Amyloidosis. Can J Cardiol. 2020 Mar; 36 (3):384-395 Epub 2019 Dec 09
    View PubMed
  57. Ingraham BS, Klarich KW, Anavekar NS, Grogan M. Metastatic Merkel Cell Carcinoma Resulting in Complete Heart Block. JACC CardioOncol. 2020 Mar; 2 (1):131-134 Epub 2020 Mar 17
    View PubMed
  58. Pinto MV, Milone M, Mauermann ML, Dyck PJB, Alhammad R, McPhail ED, Grogan M, Liewluck T. Transthyretin amyloidosis: Putting myopathy on the map. Muscle Nerve. 2020 Jan; 61 (1):95-100 Epub 2019 Oct 21
    View PubMed
  59. Muchtar E, Gertz MA, Lacy MQ, Go RS, Buadi FK, Dingli D, Grogan M, AbouEzzeddine OF, Hayman SR, Kapoor P, Leung N, Fonder A, Hobbs M, Hwa YL, Gonsalves W, Warsame R, Kourelis TV, Russell S, Lust JA, Lin Y, Zeldenrust S, Kyle RA, Rajkumar SV, Kumar SK, Dispenzieri A. Ten-year survivors in AL amyloidosis: characteristics and treatment pattern. Br J Haematol. 2019 Dec; 187 (5):588-594 Epub 2019 July 12
    View PubMed
  60. Gertz MA, Mauermann ML, Grogan M, Coelho T. Advances in the treatment of hereditary transthyretin amyloidosis: A review. Brain Behav. 2019 Sep; 9 (9):e01371 Epub 2019 Aug 01
    View PubMed
  61. Maurer MS, Bokhari S, Damy T, Dorbala S, Drachman BM, Fontana M, Grogan M, Kristen AV, Lousada I, Nativi-Nicolau J, Cristina Quarta C, Rapezzi C, Ruberg FL, Witteles R, Merlini G. Expert Consensus Recommendations for the Suspicion and Diagnosis of Transthyretin Cardiac Amyloidosis. Circ Heart Fail. 2019 Sep; 12 (9):e006075 Epub 2019 Sept 04
    View PubMed
  62. Pislaru C, Ionescu F, Alashry M, Petrescu I, Pellikka PA, Grogan M, Dispenzieri A, Pislaru SV. Myocardial Stiffness by Intrinsic Cardiac Elastography in Patients with Amyloidosis: Comparison with Chamber Stiffness and Global Longitudinal Strain. J Am Soc Echocardiogr. 2019 Aug; 32 (8):958-968.e4 Epub 2019 June 21
    View PubMed
  63. Judge DP, Heitner SB, Falk RH, Maurer MS, Shah SJ, Witteles RM, Grogan M, Selby VN, Jacoby D, Hanna M, Nativi-Nicolau J, Patel J, Rao S, Sinha U, Turtle CW, Fox JC. Transthyretin Stabilization by AG10 in Symptomatic Transthyretin Amyloid Cardiomyopathy. J Am Coll Cardiol. 2019 Jul 23; 74 (3):285-295 Epub 2019 Mar 15
    View PubMed
  64. Ruberg FL, Grogan M, Hanna M, Kelly JW, Maurer MS. Transthyretin Amyloid Cardiomyopathy: JACC State-of-the-Art Review. J Am Coll Cardiol. 2019 Jun 11; 73 (22):2872-2891
    View PubMed
  65. El-Am EA, Dispenzieri A, Grogan M, Nkomo VT. Reply: Cardiac Amyloidosis, Atrial Arrhythmias, Thrombus, and Stroke: A Vexing Problem. J Am Coll Cardiol 2019 Jun 11; 73 (22):2911-2913
    View PubMed
  66. Sidiqi MH, Dasari S, McPhail ED, Buadi FK, Warsame R, Lacy MQ, Dingli D, Gonsalves WI, Kapoor P, Kourelis T, Leung N, Muchtar E, Grogan M, Lust JA, Kumar S, Kyle RA, Rajkumar VS, Gertz M, Dispenzieri A. Monoclonal gammopathy plus positive amyloid biopsy does not always equal AL amyloidosis. Am J Hematol 2019 May; 94 (5):E141-E143 Epub 2019 Feb 27
    View PubMed
  67. Pinto MV, Tracy JA, Grogan M, Mauermann ML. Teaching NeuroImages: Neuromyopathy in a patient with hereditary transthyretin Thr60Ala amyloidosis. Neurology. 2019 Mar 19; 92 (12):e1403-e1404
    View PubMed
  68. Sidiqi MH, McPhail ED, Theis JD, Dasari S, Vrana JA, Drosou ME, Leung N, Hayman S, Rajkumar SV, Warsame R, Ansell SM, Gertz MA, Grogan M, Dispenzieri A. Two types of amyloidosis presenting in a single patient: a case series. Blood Cancer J. 2019 Mar 5; 9 (3):30 Epub 2019 Mar 05
    View PubMed
  69. Sidana S, Tandon N, Brady PA, Grogan M, Gertz MA, Dispenzieri A, Lin G, Dingli D, Buadi FK, Lacy MQ, Kapoor P, Gonsalves WI, Muchtar E, Warsame R, Kumar SK, Kourelis TV. Prognostic Significance of Holter Monitor Findings in Patients With Light Chain Amyloidosis. Mayo Clin Proc. 2019 Mar; 94 (3):455-464 Epub 2019 Feb 02
    View PubMed
  70. Chang IC, Dispenzieri A, Scott CG, Lin G, Jaffe AS, Klarich KW, Grogan M. Utility of the Serum Free Light Chain Assay in the Diagnosis of Light Chain Amyloidosis in Patients With Heart Failure. Mayo Clin Proc. 2019 Mar; 94 (3):447-454 Epub 2019 Feb 02
    View PubMed
  71. El-Am EA, Dispenzieri A, Melduni RM, Ammash NM, White RD, Hodge DO, Noseworthy PA, Lin G, Pislaru SV, Egbe AC, Grogan M, Nkomo VT. Direct Current Cardioversion of Atrial Arrhythmias in Adults With Cardiac Amyloidosis. J Am Coll Cardiol. 2019 Feb 12; 73 (5):589-597
    View PubMed
  72. Pislaru C, Alashry MM, Ionescu F, Petrescu I, Pellikka PA, Grogan M, Dispenzieri A, Pislaru SV. Increased Myocardial Stiffness Detected by Intrinsic Cardiac Elastography in Patients With Amyloidosis: Impact on Outcomes. JACC Cardiovasc Imaging 2019 Feb; 12 (2):375-377 Epub 2018 Oct 17
    View PubMed
  73. Solomon SD, Adams D, Kristen A, Grogan M, Gonzalez-Duarte A, Maurer MS, Merlini G, Damy T, Slama MS, Brannagan TH 3rd, Dispenzieri A, Berk JL, Shah AM, Garg P, Vaishnaw A, Karsten V, Chen J, Gollob J, Vest J, Suhr O. Effects of Patisiran, an RNA Interference Therapeutic, on Cardiac Parameters in Patients With Hereditary Transthyretin-Mediated Amyloidosis. Circulation. 2019 Jan 22; 139 (4):431-443
    View PubMed
  74. Lee SP, Park JB, Kim HK, Kim YJ, Grogan M, Sohn DW. Contemporary Imaging Diagnosis of Cardiac Amyloidosis. J Cardiovasc Imaging. 2019 Jan; 27 (1):1-10
    View PubMed
  75. Chang IC, Scott CG, Dispenzieri A, AbouEzzeddine O, Lin G, Grogan M. Transthyretin amyloidosis in patients with undifferentiated heart failure. Amyloid. 2019; 26 (sup1):33-34
    View PubMed
  76. Muchtar E, Dispenzieri A, Leung N, Lacy MQ, Buadi FK, Dingli D, Grogan M, Hayman SR, Kapoor P, Hwa YL, Fonder A, Hobbs M, Chakraborty R, Gonsalves W, Kourelis TV, Warsame R, Russell S, Lust JA, Lin Y, Go RS, Zeldenrust S, Kyle RA, Rajkumar SV, Kumar SK, Gertz MA. Depth of organ response in AL amyloidosis is associated with improved survival: new proposed organ response criteria. Amyloid. 2019; 26(sup1):101-102.
    View PubMed
  77. Rosenbaum AN, AbouEzzeddine OF, Grogan M, Dispenzieri A, Kushwaha S, Clavell A, Daly RC, Edwards BS. Outcomes After Cardiac Transplant for Wild Type Transthyretin Amyloidosis. Transplantation. 2018 Nov; 102 (11):1909-1913
    View PubMed
  78. Mankad , R., Grogan , M.. Diagnosis of Cardiac Amyloidosis: Clinical and echocardiographic Features Current Cardiovascular Imaging Reports. 2018; 11(32).
  79. Muchtar E, Dispenzieri A, Leung N, Lacy MQ, Buadi FK, Dingli D, Grogan M, Hayman SR, Kapoor P, Hwa YL, Fonder A, Hobbs M, Chakraborty R, Gonsalves W, Kourelis TV, Warsame R, Russell S, Lust JA, Lin Y, Go RS, Zeldenrust S, Kyle RA, Rajkumar SV, Kumar SK, Gertz MA. Depth of organ response in AL amyloidosis is associated with improved survival: grading the organ response criteria. Leukemia. 2018 Oct; 32 (10):2240-2249 Epub 2018 Feb 20
    View PubMed
  80. Maurer MS, Schwartz JH, Gundapaneni B, Elliott PM, Merlini G, Waddington-Cruz M, Kristen AV, Grogan M, Witteles R, Damy T, Drachman BM, Shah SJ, Hanna M, Judge DP, Barsdorf AI, Huber P, Patterson TA, Riley S, Schumacher J, Stewart M, Sultan MB, Rapezzi C, ATTR-ACT Study Investigators. Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy. N Engl J Med. 2018 Sep 13; 379 (11):1007-1016 Epub 2018 Aug 27
    View PubMed
  81. Java AP, Greason KL, Dispenzieri A, Grogan M, King KS, Maleszewski JJ, Daly RC, Eleid MF, Pochettino A, Schaff HV. Aortic valve replacement in patients with amyloidosis. J Thorac Cardiovasc Surg. 2018 Jul; 156 (1):98-103 Epub 2017 Dec 19
    View PubMed
  82. Muchtar E, Gertz MA, Kumar SK, Lin G, Boilson B, Clavell A, Lacy MQ, Buadi FK, Hayman SR, Kapoor P, Dingli D, Rajkumar SV, Dispenzieri A, Grogan M. Digoxin use in systemic light-chain (AL) amyloidosis: contra-indicated or cautious use? Amyloid. 2018 Jun; 25 (2):86-92 Epub 2018 Mar 12
    View PubMed
  83. Illman JE, Arunachalam SP, Arani A, Chang IC, Glockner JF, Dispenzieri A, Grogan M, Araoz PA. MRI feature tracking strain is prognostic for all-cause mortality in AL amyloidosis. Amyloid. 2018 Jun; 25(2):101-108. Epub 2018 May 07.
    View PubMed
  84. Milani P, Dispenzieri A, Scott CG, Gertz MA, Perlini S, Mussinelli R, Lacy MQ, Buadi FK, Kumar S, Maurer MS, Merlini G, Hayman SR, Leung N, Dingli D, Klarich KW, Lust JA, Lin Y, Kapoor P, Go RS, Pellikka PA, Hwa YL, Zeldenrust SR, Kyle RA, Rajkumar SV, Grogan M. Independent Prognostic Value of Stroke Volume Index in Patients With Immunoglobulin Light Chain Amyloidosis. Circ Cardiovasc Imaging. 2018 May; 11 (5):e006588
    View PubMed
  85. Pereira NL, Grogan M, Dec GW. Spectrum of Restrictive and Infiltrative Cardiomyopathies: Part 1 of a 2-Part Series. J Am Coll Cardiol. 2018 Mar 13; 71 (10):1130-1148
    View PubMed
  86. Pereira NL, Grogan M, Dec GW. Spectrum of Restrictive and Infiltrative Cardiomyopathies: Part 2 of a 2-Part Series. J Am Coll Cardiol. 2018 Mar 13; 71 (10):1149-1166
    View PubMed
  87. Chang ICY, Bois JP, Bois MC, Maleszewski JJ, Johnson GB, Grogan M. Hydroxychloroquine-Mediated Cardiotoxicity With a False-Positive 99mTechnetium-Labeled Pyrophosphate Scan for Transthyretin-Related Cardiac Amyloidosis. Circ Cardiovasc Imaging. 2018 Jan; 11(1).
    View PubMed
  88. Arani A, Arunachalam SP, Chang ICY, Baffour F, Rossman PJ, Glaser KJ, Trzasko JD, McGee KP, Manduca A, Grogan M, Dispenzieri A, Ehman RL, Araoz PA. Cardiac MR elastography for quantitative assessment of elevated myocardial stiffness in cardiac amyloidosis. J Magn Reson Imaging. 2017 Nov; 46(5):1361-1367. Epub 2017 Feb 25.
    View PubMed
  89. Kapoor P, Ansell SM, Fonseca R, Chanan-Khan A, Kyle RA, Kumar SK, Mikhael JR, Witzig TE, Mauermann M, Dispenzieri A, Ailawadhi S, Stewart AK, Lacy MQ, Thompson CA, Buadi FK, Dingli D, Morice WG, Go RS, Jevremovic D, Sher T, King RL, Braggio E, Novak A, Roy V, Ketterling RP, Greipp PT, Grogan M, Micallef IN, Bergsagel PL, Colgan JP, Leung N, Gonsalves WI, Lin Y, Inwards DJ, Hayman SR, Nowakowski GS, Johnston PB, Russell SJ, Markovic SN, Zeldenrust SR, Hwa YL, Lust JA, Porrata LF, Habermann TM, Rajkumar SV, Gertz MA, Reeder CB. Diagnosis and Management of Waldenstrom Macroglobulinemia: Mayo Stratification of Macroglobulinemia and Risk-Adapted Therapy (mSMART) Guidelines 2016. JAMA Oncol. 2017 Sep 1; 3 (9):1257-1265
    View PubMed
  90. Banerjee D, Roeker LE, Grogan M, Swiecicki P, Poterucha J, Heimbach J, Zeldenrust S, Gertz M, Edwards B, Daly R, Klarich KW, Dispenzieri A. Outcomes of Patients With Familial Transthyretin Amyloidosis After Liver Transplantation. Prog Transplant. 2017 Sep; 27 (3):246-250 Epub 2017 July 04
    View PubMed
  91. Muchtar E, Grogan M, Dasari S, Kurtin PJ, Gertz MA. Acquired transthyretin amyloidosis after domino liver transplant: Phenotypic correlation, implication of liver retransplantation. J Neurol Sci. 2017 Aug 15; 379:192-197 Epub 2017 June 13
    View PubMed
  92. Grogan M, Dispenzieri A, Gertz MA. Light-chain cardiac amyloidosis: strategies to promote early diagnosis and cardiac response. Heart. 2017 Jul; 103 (14):1065-1072 Epub 2017 Apr 29
    View PubMed
  93. Bois MC, Dasari S, Mills JR, Theis J, Highsmith WE, Vrana JA, Grogan M, Dispenzieri A, Kurtin PJ, Maleszewski JJ. Apolipoprotein A-IV-Associated Cardiac Amyloidosis. J Am Coll Cardiol 2017 May 2; 69 (17):2248-2249
    View PubMed
  94. Muchtar E, Gertz MA, Kumar SK, Lacy MQ, Dingli D, Buadi FK, Grogan M, Hayman SR, Kapoor P, Leung N, Fonder A, Hobbs M, Hwa YL, Gonsalves W, Warsame R, Kourelis TV, Russell S, Lust JA, Lin Y, Go RS, Zeldenrust S, Kyle RA, Rajkumar SV, Dispenzieri A. Improved outcomes for newly diagnosed AL amyloidosis between 2000 and 2014: cracking the glass ceiling of early death. Blood. 2017 Apr 13; 129 (15):2111-2119 Epub 2017 Jan 26
    View PubMed
  95. Barros-Gomes S, Williams B, Nhola LF, Grogan M, Maalouf JF, Dispenzieri A, Pellikka PA, Villarraga HR. Prognosis of Light Chain Amyloidosis With Preserved LVEF: Added Value of 2D Speckle-Tracking Echocardiography to the Current Prognostic Staging System. JACC Cardiovasc Imaging. 2017 Apr; 10 (4):398-407 Epub 2016 Sept 14
    View PubMed
  96. Maurer M, Lousada I, Hanna M, Ruberg F, Mohty D, Dispenzieri A, Liedtke M, Paulson I, Vest J, Grogan M. Recommendations from the Amyloidosis Research Consortium Educational Roundtable at the American College of Cardiology Annual Meeting, 1 April 2016. Amyloid. 2017 Mar; 24 (sup1):165-166
    View PubMed
  97. Chang ICY, Arani A, Poigai Arunachalam S, Grogan M, Dispenzieri A, Araoz PA. Feasibility study of cardiac magnetic resonance elastography in cardiac amyloidosis. Amyloid. 2017 Mar; 24(sup1):161.
    View PubMed
  98. Sperry BW, Dispenzieri A, Ikram A, Grogan M, Theis JD, Leung N, Highsmith WE, Maleszewski JJ, Hanna M. Complex p.T88N/W130R mutation in the lysozyme gene leading to hereditary lysozyme amyloidosis with biopsy-proven cardiac involvement. Amyloid 2017 Mar; 24 (1):60-61 Epub 2017 Mar 22
    View PubMed
  99. El Sabbagh A, Al-Hijji MA, Thaden JJ, Pislaru SV, Pislaru C, Pellikka PA, Arruda-Olson AM, Grogan M, Greason KL, Maleszewski JJ, Klarich KW, Nkomo VT. Cardiac Myxoma: The Great Mimicker. JACC Cardiovasc Imaging. 2017 Feb; 10 (2):203-206
    View PubMed
  100. Castano A, Haq M, Narotsky DL, Goldsmith J, Weinberg RL, Morgenstern R, Pozniakoff T, Ruberg FL, Miller EJ, Berk JL, Dispenzieri A, Grogan M, Johnson G, Bokhari S, Maurer MS. Multicenter Study of Planar Technetium 99m Pyrophosphate Cardiac Imaging: Predicting Survival for Patients With ATTR Cardiac Amyloidosis. JAMA Cardiol. 2016 Nov 1; 1 (8):880-889
    View PubMed
  101. Merlini G, Lousada I, Ando Y, Dispenzieri A, Gertz MA, Grogan M, Maurer MS, Sanchorawala V, Wechalekar A, Palladini G, Comenzo RL. Rationale, application and clinical qualification for NT-proBNP as a surrogate end point in pivotal clinical trials in patients with AL amyloidosis. Leukemia. 2016 Oct; 30 (10):1979-1986 Epub 2016 July 15
    View PubMed
  102. Tan NY, Mohsin Y, Hodge DO, Lacy MQ, Packer DL, Dispenzieri A, Grogan M, Asirvatham SJ, Madhavan M, McLEOD CJ. Catheter Ablation for Atrial Arrhythmias in Patients With Cardiac Amyloidosis. J Cardiovasc Electrophysiol. 2016 Oct; 27 (10):1167-1173 Epub 2016 Aug 26
    View PubMed
  103. Saiki H, Eidem BW, Ohtani T, Grogan MA, Redfield MM. Ventricular-Arterial Function and Coupling in the Adult Fontan Circulation. J Am Heart Assoc. 2016 Sep 23; 5 (9) Epub 2016 Sept 23
    View PubMed
  104. Grogan M, Scott CG, Kyle RA, Zeldenrust SR, Gertz MA, Lin G, Klarich KW, Miller WL, Maleszewski JJ, Dispenzieri A. Natural History of Wild-Type Transthyretin Cardiac Amyloidosis and Risk Stratification Using a Novel Staging System. J Am Coll Cardiol. 2016 Sep 6; 68 (10):1014-20
    View PubMed
  105. Maurer MS, Hanna M, Grogan M, Dispenzieri A, Witteles R, Drachman B, Judge DP, Lenihan DJ, Gottlieb SS, Shah SJ, Steidley DE, Ventura H, Murali S, Silver MA, Jacoby D, Fedson S, Hummel SL, Kristen AV, Damy T, Plante-Bordeneuve V, Coelho T, Mundayat R, Suhr OB, Waddington Cruz M, Rapezzi C, THAOS Investigators. Genotype and Phenotype of Transthyretin Cardiac Amyloidosis: THAOS (Transthyretin Amyloid Outcome Survey). J Am Coll Cardiol. 2016 Jul 12; 68 (2):161-72
    View PubMed
  106. Liang JJ, Grogan M, Ackerman MJ. LMNA-Mediated Arrhythmogenic Right Ventricular Cardiomyopathy and Charcot-Marie-Tooth Type 2B1: A Patient-Discovered Unifying Diagnosis. J Cardiovasc Electrophysiol. 2016 Jul; 27: (7)868-71.
    View PubMed
  107. Grogan M, Gertz M, McCurdy A, Roeker L, Kyle R, Kushwaha S, Daly R, Dearani J, Rodeheffer R, Frantz R, Lacy M, Hayman S, McGregor C, Edwards B, Dispenzieri A. Long term outcomes of cardiac transplant for immunoglobulin light chain amyloidosis: The Mayo Clinic experience. World J Transplant. 2016 Jun 24; 6 (2):380-8
    View PubMed
  108. Gillmore JD, Maurer MS, Falk RH, Merlini G, Damy T, Dispenzieri A, Wechalekar AD, Berk JL, Quarta CC, Grogan M, Lachmann HJ, Bokhari S, Castano A, Dorbala S, Johnson GB, Glaudemans AW, Rezk T, Fontana M, Palladini G, Milani P, Guidalotti PL, Flatman K, Lane T, Vonberg FW, Whelan CJ, Moon JC, Ruberg FL, Miller EJ, Hutt DF, Hazenberg BP, Rapezzi C, Hawkins PN. Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis. Circulation. 2016 Jun 14; 133 (24):2404-12 Epub 2016 Apr 22
    View PubMed
  109. Boynton SJ, Geske JB, Dispenzieri A, Syed IS, Hanson TJ, Grogan M, Araoz PA. LGE Provides Incremental Prognostic Information Over Serum Biomarkers in AL Cardiac Amyloidosis. JACC Cardiovasc Imaging. 2016 Jun; 9 (6):680-6 Epub 2016 May 18
    View PubMed
  110. Ong KC, Askew JW, Dispenzieri A, Maleszewski JJ, Klarich KW, Anavekar NS, Mulvagh SL, Grogan M. Abnormal stress echocardiography findings in cardiac amyloidosis. Amyloid. 2016 Jun; 23: (2)124-31.
    View PubMed
  111. Okamura H, McLeod CJ, DeSimone CV, Webster TL, Bonnichsen CR, Grogan M, Phillips SD, Connolly HM, Ammash NM, Warnes CA, Friedman PA. Right Parasternal Lead Placement Increases Eligibility for Subcutaneous Implantable Cardioverter Defibrillator Therapy in Adults With Congenital Heart Disease. Circ J. 2016 May 25; 80 (6):1328-35 Epub 2016 Apr 22
    View PubMed
  112. Larsen BT, Mereuta OM, Dasari S, Fayyaz AU, Theis JD, Vrana JA, Grogan M, Dogan A, Dispenzieri A, Edwards WD, Kurtin PJ, Maleszewski JJ. Correlation of histomorphological pattern of cardiac amyloid deposition with amyloid type: a histological and proteomic analysis of 108 cases. Histopathology. 2016 Apr; 68 (5):648-56 Epub 2015 Sept 28
    View PubMed
  113. Gertz MA, Benson MD, Dyck PJ, Grogan M, Coelho T, Cruz M, Berk JL, Plante-Bordeneuve V, Schmidt HHJ, Merlini G. Diagnosis, Prognosis, and Therapy of Transthyretin Amyloidosis. J Am Coll Cardiol. 2015 Dec 1; 66 (21):2451-2466
    View PubMed
  114. Dispenzieri A, Buadi F, Kumar SK, Reeder CB, Sher T, Lacy MQ, Kyle RA, Mikhael JR, Roy V, Leung N, Grogan M, Kapoor P, Lust JA, Dingli D, Go RS, Hwa YL, Hayman SR, Fonseca R, Ailawadhi S, Bergsagel PL, Chanan-Khan A, Rajkumar SV, Russell SJ, Stewart K, Zeldenrust SR, Gertz MA. Treatment of Immunoglobulin Light Chain Amyloidosis: Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consensus Statement. Mayo Clin Proc. 2015 Aug; 90(8):1054-81.
    View PubMed
  115. Swiecicki PL, Zhen DB, Mauermann ML, Kyle RA, Zeldenrust SR, Grogan M, Dispenzieri A, Gertz MA. Hereditary attr amyloidosis: a single-institution experience with 266 patients. Amyloid. 2015 Jun; 22(2):123-31.
    View PubMed
  116. Dispenzieri A, Gertz MA, Saenger A, Kumar SK, Lacy MQ, Buadi FK, Dingli D, Leung N, Zeldenrust S, Hayman SR, Kapoor P, Grogan M, Hwa L, Russell SJ, Go RS, Rajkumar SV, Kyle RA, Jaffe A. Soluble suppression of tumorigenicity 2 (sST2), but not galactin-3, adds to prognostication in patients with systemic AL amyloidosis independent of NT-proBNP and troponin T. Am J Hematol. 2015 Jun; 90: (6)524-8.
    View PubMed
  117. Grogan M, Dispenzieri A. Natural history and therapy of AL cardiac amyloidosis. Heart Fail Rev. 2015 Mar; 20 (2):155-62
    View PubMed
  118. Leung N, Grogan M, Johnson GB, Klecka ME, Dispenzeiri A. Pulmonary masses in a patient with dyspnea: Apply Occam's razor or Hickam's dictum? Am J Hematol. 2015; 90(5):462-5.
    View PubMed
  119. Sabate Rotes A, Burkhart HM, Suri RM, Grogan M, Taggart NW, Li Z, Schaff HV, Dearani JA. Minimally invasive video-assisted surgical closure of atrial septal defects: a safe approach. World J Pediatr Congenit Heart Surg. 2014 Oct; 5 (4):527-33
    View PubMed
  120. Raju V, Dearani JA, Burkhart HM, Grogan M, Phillips SD, Ammash N, Pike RP, Johnson JN, O'Leary PW. Right ventricular unloading for heart failure related to Ebstein malformation. Ann Thorac Surg. 2014 Jul; 98(1):167-73; discussion 173-4. Epub 2014 May 6
    View PubMed
  121. Fine NM, Arruda-Olson AM, Dispenzieri A, Zeldenrust SR, Gertz MA, Kyle RA, Swiecicki PL, Scott CG, Grogan M. Yield of noncardiac biopsy for the diagnosis of transthyretin cardiac amyloidosis. Am J Cardiol. 2014 May 15; 113 (10):1723-7 Epub 2014 Mar 02
    View PubMed
  122. Suresh R, Grogan M, Maleszewski JJ, Pellikka PA, Hanna M, Dispenzieri A, Pereira NL. Advanced cardiac amyloidosis associated with normal interventricular septal thickness: an uncommon presentation of infiltrative cardiomyopathy. J Am Soc Echocardiogr. 2014 Apr; 27 (4):440-7 Epub 2014 Jan 18
    View PubMed
  123. Dispenzieri A, Gertz MA, Kumar SK, Lacy MQ, Kyle RA, Saenger AK, Grogan M, Zeldenrust SR, Hayman SR, Buadi F, Greipp PR, Leung N, Russell SR, Dingli D, Lust JA, Rajkumar SV, Jaffe AS. High sensitivity cardiac troponin T in patients with immunoglobulin light chain amyloidosis. Heart. 2014 Mar; 100 (5):383-8 Epub 2014 Jan 08
    View PubMed
  124. Arruda-Olson AM, Zeldenrust SR, Dispenzieri A, Gertz MA, Miller FA, Bielinski SJ, Klarich KW, Scott CG, Grogan M. Genotype, echocardiography, and survival in familial transthyretin amyloidosis. Amyloid. 2013 Dec; 20 (4):263-8 Epub 2013 Oct 16
    View PubMed
  125. Brenes-Salazar JA, Grogan M, Lacy MQ. A 66-year-old woman with an enlarged tongue. Cleve Clin J Med. 2013 Nov; 80(11):696-7.
    View PubMed
  126. Lin G, Dispenzieri A, Kyle R, Grogan M, Brady PA. Implantable cardioverter defibrillators in patients with cardiac amyloidosis. J Cardiovasc Electrophysiol. 2013 Jul; 24(7):793-8. Epub 2013 Mar 14.
    View PubMed
  127. Maleszewski JJ, Murray DL, Dispenzieri A, Grogan M, Pereira NL, Jenkins SM, Judge DP, Caturegli P, Vrana JA, Theis JD, Dogan A, Halushka MK. Relationship between monoclonal gammopathy and cardiac amyloid type. Cardiovasc Pathol. 2013 May-Jun; 22 (3):189-94 Epub 2012 Oct 24
    View PubMed
  128. Hussain FT, Grogan M, Dearani JA. Surgical repair of tetralogy of fallot at age 83. World J Pediatr Congenit Heart Surg. 2012 Oct 1; 3(4):518-20.
    View PubMed
  129. Bellavia D, Pellikka PA, Dispenzieri A, Scott CG, Al-Zahrani GB, Grogan M, Pitrolo F, Oh JK, Miller FA Jr. Comparison of right ventricular longitudinal strain imaging, tricuspid annular plane systolic excursion, and cardiac biomarkers for early diagnosis of cardiac involvement and risk stratification in primary systematic (AL) amyloidosis: a 5-year cohort study. Eur Heart J Cardiovasc Imaging. 2012 Aug; 13 (8):680-9 Epub 2012 Feb 03
    View PubMed
  130. Bonnichsen CR, Glockner JF, Grogan M. Improvement in myocardial delayed enhancement after autologous stem cell transplant in a patient with light chain amyloidosis. Circ Heart Fail. 2012 May 1; 5(3):e55.
    View PubMed
  131. Madan S, Kumar SK, Dispenzieri A, Lacy MQ, Hayman SR, Buadi FK, Dingli D, Rajkumar SV, Hogan WJ, Leung N, Grogan M, Gertz MA. High-dose melphalan and peripheral blood stem cell transplantation for light-chain amyloidosis with cardiac involvement. Blood. 2012 Feb 2; 119 (5):1117-22 Epub 2011 Dec 06
    View PubMed
  132. Lee GK, Klarich KW, Grogan M, Cha YM. Premature ventricular contraction-induced cardiomyopathy: a treatable condition. Circ Arrhythm Electrophysiol. 2012 Feb; 5 (1):229-36
    View PubMed
  133. Shah DK, Joyce LD, Grogan M, Aubry MC, Miller JA, Ding W, Haddock MG. Recurrent pulmonary intimal sarcoma involving the right ventricular outflow tract. Ann Thorac Surg. 2011 Mar; 91: (3)e41-2.
    View PubMed
  134. Syed IS, Glockner JF, Feng D, Araoz PA, Martinez MW, Edwards WD, Gertz MA, Dispenzieri A, Oh JK, Bellavia D, Tajik AJ, Grogan M. Role of cardiac magnetic resonance imaging in the detection of cardiac amyloidosis. JACC Cardiovasc Imaging. 2010 Feb; 3 (2):155-64
    View PubMed
  135. Fealey ME, Edwards WD, Buadi FK, Syed IS, Grogan M. Echocardiographic features of cardiac amyloidosis presenting as endomyocardial disease in a 54-year-old male. J Cardiol. 2009 Aug; 54: (1)162-6.
    View PubMed
  136. Feng D, Syed IS, Martinez M, Oh JK, Jaffe AS, Grogan M, Edwards WD, Gertz MA, Klarich KW. Intracardiac thrombosis and anticoagulation therapy in cardiac amyloidosis. Circulation. 2009 May 12; 119(18):2490-7. Epub 2009 May 04.
    View PubMed
  137. Rehfeldt KH, Mauermann WJ, Suri RM, Grogan M. The diagnosis of Shone's anomaly by intraoperative transesophageal echocardiography. J Cardiothorac Vasc Anesth. 2009 Feb; 23: (1)75-6.
    View PubMed
  138. Fealey ME, Edwards WD, Grogan M, Orszulak TA. Neuronal ceroid lipofuscinosis in a 31-year-old woman presenting as biventricular heart failure with restrictive features. Cardiovasc Pathol. 2009 Jan-Feb; 18(1):44-8. Epub 2007 Nov 19.
    View PubMed
  139. Silvilairat S, Cabalka AK, Cetta F, Grogan M, Hagler DJ, O'Leary PW. Protein-losing enteropathy after the Fontan operation: associations and predictors of clinical outcome. Congenit Heart Dis. 2008 Jul-Aug; 3(4):262-8.
    View PubMed
  140. Feng D, Edwards WD, Oh JK, Chandrasekaran K, Grogan M, Martinez MW, Syed II, Hughes DA, Lust JA, Jaffe AS, Gertz MA, Klarich KW. Intracardiac thrombosis and embolism in patients with cardiac amyloidosis. Circulation. 2007 Nov 20; 116(21):2420-6.
    View PubMed
  141. Fealey ME, Edwards WD, Grogan M, Dispenzieri A. Primary cardiac amyloidosis with 20-year survival. Cardiovasc Pathol. 2006 Nov-Dec; 15(6):331-5.
    View PubMed
  142. Earing MG, Connolly HM, Dearani JA, Ammash NM, Grogan M, Warnes CA. Long-term follow-up of patients after surgical treatment for isolated pulmonary valve stenosis. Mayo Clin Proc. 2005 Jul; 80: (7)871-6.
    View PubMed
  143. Qaddoura F, Connolly H, Grogan M, Orszulak TA, Schaff HV, Chandrasekaran K, Click RL. Valve morphology in antiphospholipid antibody syndrome: echocardiographic features. Echocardiography. 2005 Mar; 22(3):255-9.
    View PubMed
  144. Murtagh B, Hammill SC, Gertz MA, Kyle RA, Tajik AJ, Grogan M. Electrocardiographic findings in primary systemic amyloidosis and biopsy-proven cardiac involvement. Am J Cardiol. 2005 Feb 15; 95(4):535-7.
    View PubMed
  145. Beauchesne LM, Warnes CA, Connolly HM, Ammash NM, Grogan M, Jalal SM, Michels VV. Prevalence and clinical manifestations of 22q11.2 microdeletion in adults with selected conotruncal anomalies. J Am Coll Cardiol. 2005 Feb 15; 45(4):595-8.
    View PubMed
  146. Veldtman GR, Connolly HM, Grogan M, Ammash NM, Warnes CA. Outcomes of pregnancy in women with tetralogy of Fallot. J Am Coll Cardiol. 2004 Jul 7; 44(1):174-80.
    View PubMed
  147. Grogan M, Warnes CA. The adult with successful childhood repair of ASD/coarctation/or VSD: what should I watch for? ACC Current Journal Review. 2003 Jan-Feb; 12(1):97-100.
  148. Teramae CY, Connolly HM, Grogan M, Miller FA Jr. Diet drug-related cardiac valve disease: the Mayo Clinic echocardiographic laboratory experience. Mayo Clin Proc. 2000 May; 75 (5):456-61
    View PubMed
  149. Grogan M, Gertz MA, Kyle RA, Tajik AJ. Five or more years of survival in patients with primary systemic amyloidosis and biopsy-proven cardiac involvement. Am J Cardiol. 2000 Mar 1; 85 (5):664-5, A11
    View PubMed
  150. Hensrud DD, Connolly HM, Grogan M, Miller FA, Bailey KR, Jensen MD. Echocardiographic improvement over time after cessation of use of fenfluramine and phentermine. Mayo Clin Proc. 1999 Dec; 74: (12)1191-7.
    View PubMed
  151. Connolly HM, Grogan M, Warnes CA. Pregnancy among women with congenitally corrected transposition of great arteries. J Am Coll Cardiol. 1999 May; 33 (6):1692-5
    View PubMed
  152. Grogan M, Klarich KW. Coronary artery disease in Women: Evaluation and Prevention. Your Patient & Fitness. 1998 Jul/Aug; 12(4):6-10.
  153. Sutton-Tyrrell K, Rihal C, Sellers MA, Rihal C, Burek K, Trudel J, Roubin G, Brooks MM, Grogan M, Sopko G, Keller N, Jandova R. Long-term prognostic value of clinically evident noncoronary vascular disease in patients undergoing coronary revascularization in the Bypass Angioplasty Revascularization Investigation (BARI). Am J Cardiol. 1998 Feb 15; 81 (4):375-81
    View PubMed
  154. Grogan M, Klarich KW, Smith HC. Heart disease in women. Your Patient and Fitness. 1998; 12(4):6-10.
  155. Gertz MA, Grogan M, Kyle RA, Tajik AJ. Endomyocardial biopsy-proven light chain amyloidosis (AL) without echocardiographic features of infiltrative cardiomyopathy. Am J Cardiol. 1997 Jul 1; 80 (1):93-5
    View PubMed
  156. Grogan M, Redfield MM, Bailey KR, Reeder GS, Gersh BJ, Edwards WD, Rodeheffer RJ. Long-term outcome of patients with biopsy-proved myocarditis: comparison with idiopathic dilated cardiomyopathy. J Am Coll Cardiol. 1995 Jul; 26 (1):80-4
    View PubMed
  157. Lloyd MA, Grogan M, Sandberg SM, Smith HC, Gersh BJ, Edwards WD, Edwards BS. Presence of atrial natriuretic factor in ventricular tissue in tachycardia-induced cardiomyopathy. Am J Cardiol. 1994 May 15; 73 (13):984-6
    View PubMed
  158. Grogan M, Christian TF, Miller TD, Bailey KR, Gibbons RJ. The effect of systemic hypertension on exercise tomographic thallium-201 imaging in the absence of electrocardiographic left ventricular hypertrophy. Am Heart J. 1993 Aug; 126 (2):327-32
    View PubMed
  159. Grogan M, Smith HC, Gersh BJ, Wood DL. Left ventricular dysfunction due to atrial fibrillation in patients initially believed to have idiopathic dilated cardiomyopathy. Am J Cardiol. 1992 Jun 15; 69 (19):1570-3
    View PubMed